Ceramide-mediated clustering is required for CD95-DISC formation

被引:224
作者
Grassmé, H
Cremesti, A
Kolesnick, R
Gulbins, E
机构
[1] Univ Duisburg Essen, Dept Mol Biol, D-45122 Essen, Germany
[2] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA
关键词
receptor aggregation; ceramide; acid sphingomyelinase; CD95; apoptosis;
D O I
10.1038/sj.onc.1206540
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Early events required for induction of apoptosis by CD95 are preassociation of CD95, the formation of the death-inducing signaling complex (DISC) and clustering of CD95 in distinct membrane domains. Here, we identify the molecular ordering of these events and show that the acid sphingomyelinase (ASM) functions upstream of the DISC to mediate CD95 clustering in ceramide-enriched membrane platforms, an event that is required for DISC formation. Experiments in ASM-deficient cells revealed that CD95 ligation, in the absence of ceramide generation, triggers <1% of full caspase 8 activation at the receptor. This event, however, is both necessary and sufficient to trigger translocation of ASM onto the outer leaflet of the plasma membrane, ASM activation and ceramide release, but insufficient for apoptosis induction. Ceramide-mediated CD95 clustering then amplifies the primary CD95 signaling and drives the second step of CD95 signaling, that is, formation of the DISC yielding 100% caspase activity and apoptosis. These studies suggest that the most parsimonious interpretation of the molecular ordering of the earliest events in CD95 signaling, at least in some cells, is: CD95 ligation→1% of maximum caspase 8 activation→ASM translocation→ceramide generation→CD95 clustering→DISC formation→100% of maximum caspase 8 activation→apoptosis.
引用
收藏
页码:5457 / 5470
页数:14
相关论文
共 46 条
[31]   Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2 [J].
Rudel, T ;
Bokoch, GM .
SCIENCE, 1997, 276 (5318) :1571-1574
[32]  
Rudner J, 2001, J CELL SCI, V114, P4161
[33]  
Sakata K, 1998, EUR J IMMUNOL, V28, P2648, DOI 10.1002/(SICI)1521-4141(199809)28:09<2648::AID-IMMU2648>3.0.CO
[34]  
2-M
[35]   ABNORMAL TYROSINE PHOSPHORYLATION ON T-CELL RECEPTOR IN LYMPHOPROLIFERATIVE DISORDERS [J].
SAMELSON, LE ;
DAVIDSON, WF ;
MORSE, HC ;
KLAUSNER, RD .
NATURE, 1986, 324 (6098) :674-676
[36]   Acid sphingomyelinase activation requires caspase-8 but not P53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells [J].
Sawada, M ;
Nakashima, S ;
Kiyono, T ;
Yamada, J ;
Hara, S ;
Nakagawa, M ;
Shinoda, J ;
Sakai, N .
EXPERIMENTAL CELL RESEARCH, 2002, 273 (02) :157-168
[37]   Two CD95 (APO-1/Fas) signaling pathways [J].
Scaffidi, C ;
Fulda, S ;
Srinivasan, A ;
Friesen, C ;
Li, F ;
Tomaselli, KJ ;
Debatin, KM ;
Krammer, PH ;
Peter, ME .
EMBO JOURNAL, 1998, 17 (06) :1675-1687
[38]   Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity [J].
Schneider, P ;
Holler, N ;
Bodmer, JL ;
Hahne, M ;
Frei, K ;
Fontana, A ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (08) :1205-1213
[39]   TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase [J].
Schwandner, R ;
Wiegmann, K ;
Bernardo, K ;
Kreder, D ;
Krönke, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5916-5922
[40]  
SHIMENO H, 1995, BIOL PHARM BULL, V18, P1335